ArticleInsights into imaging2026

Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial.

Joyce Greidanus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.